lobbying_activities: 2667283

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2667283	63c6173f-f3b2-4a20-b59d-32991018a873	Q2	GREENBERG TRAURIG, LLP	16896	SI GROUP CLIENT SERVICES	2021	second_quarter	TOB	Monitored the following: -Congressional priorities on tobacco products and flavorings. -Federal and legislative action related to the marketing and advertising of tobacco products. -Federal excise taxes, including: H.R. 3407 / S. 411, MOMMA's Act and H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. -Federal COVID-19 relief and stimulus legislation including H.R. 1319, American Rescue Plan Act of 2021. -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)		50000		0	0	2021-07-20T18:23:17.177000-04:00